Close Menu

NEW YORK (360Dx) – Dutch biotech firm SkylineDx said on Thursday that it has been awarded a €2.7 million ($3.1 million) loan for further development of its skin cancer test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.